球状体市场 - 全球产业规模、份额、趋势、机会和预测，按类型、按方法、按来源、按应用、按地区和竞争进行细分，2020-2030 年

2024 年全球球体市场价值为 7.5284 亿美元，预计到 2030 年将达到 24.8301 亿美元，复合年增长率为 21.98%。由于全球球体市场在临床前和转化研究中的重要性日益增加，其发展势头强劲。由于 3D 细胞培养系统比传统的 2D 培养具有更高的生理准确性，研究人员正转向使用球体进行癌症生物学、干细胞研究和再生医学等应用。这些球形细胞簇可以更有效地模拟体内环境，从而为药物筛选和毒性研究提供更具预测性的模型。製药公司正在大力投资以球体为基础的平台，以降低早期药物开发的成本和失败率。生物列印、微流体和无支架培养技术的持续创新进一步增强了球体系统的功能性和可扩展性，使其更容易被更广泛的实验室和 CRO 使用。

影响市场的一个主要趋势是支援高通量筛选的自动化细胞球生成平台的快速商业化，从而帮助药物开发商缩短研发週期。人工智慧和机器学习与细胞球成像和分析的结合，使研究人员能够更精确地获得更深入的生物学见解。生技公司与学术机构之间的合作日益密切，促进了知识交流和更快的创新週期。各公司也推出了新型微孔板，例如超低附着板，以支持细胞球的稳定和可重复生长。此外，人们对类器官和患者来源的肿瘤模型的兴趣日益浓厚，也增加了对先进3D细胞培养基础设施的需求。这些发展正在推动细胞球在基础研究和应用生物医学领域从实验应用向主流应用的转变。

儘管成长强劲，但市场仍面临诸多挑战，这些挑战可能会影响其扩张速度。先进的细胞球平台和耗材成本高昂，限制了小型研究机构和新创企业的可及性。标准化仍然是一个问题，因为不同实验室的细胞球形成、培养和资料解读方案通常差异很大。关于将基于细胞球的模型研究结果转化为临床应用的监管不确定性，阻碍了其在药物审批流程中更广泛的应用。技术限制，例如如何实现细胞球的均匀大小和维持细胞球的长期活力，也仍然存在。在发展中地区，认知度有限和缺乏熟练的人员进一步阻碍了细胞球的普及。透过成本优化、技术培训和跨行业合作来应对这些挑战，对于维持长期市场成长至关重要。

关键市场驱动因素

对先进3D细胞培养模型的需求不断增长

主要市场挑战

球体形成和分析缺乏标准化

主要市场趋势

转向高通量3D筛选平台

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球球体市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（多细胞肿瘤球体 (MCTS)、神经球、乳球、肝球、胚状体）
  • 按方法（微图案化板、低细胞附着板、悬滴法、其他）
  • 依来源（细胞株、​​原代细胞、iPSC 衍生细胞）
  • 按应用（发育生物学、个人化医疗、再生医学、疾病病理学研究、药物毒性和功效测试）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美球体市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲球体市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太球体市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲球状体市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲球体市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Thermo Fisher Scientific Inc.
• Corning Incorporated
• Merck KGaA
• Lonza Group AG
• InSphero AG
• Greiner Bio-One International GmbH
• 3D Biotek LLC
• CN Bio Innovations
• Kuraray Co., Ltd.
• Tecan Group Ltd.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Spheroids Market was valued at USD 752.84 Million in 2024 and is expected to reach USD 2483.01 Million by 2030 with a CAGR of 21.98%. The Global Spheroids Market is experiencing significant momentum due to its increasing relevance across preclinical and translational research. As 3D cell culture systems offer improved physiological accuracy compared to traditional 2D cultures, researchers are shifting toward spheroids for applications such as cancer biology, stem cell research, and regenerative medicine. These spherical cell clusters mimic in vivo environments more effectively, enabling more predictive modeling for drug screening and toxicity studies. Pharmaceutical companies are investing heavily in spheroid-based platforms to reduce the cost and failure rates associated with early-stage drug development. Continuous innovation in bioprinting, microfluidics, and scaffold-free culture techniques is further enhancing the functionality and scalability of spheroid systems, making them more accessible to a broader spectrum of laboratories and CROs.

A major trend shaping the market is the rapid commercialization of automated spheroid generation platforms that support high-throughput screening, helping drug developers accelerate R&D cycles. The integration of artificial intelligence and machine learning into spheroid imaging and analysis is allowing researchers to derive deeper biological insights with greater precision. Collaborations between biotech firms and academic institutions are intensifying, fostering knowledge exchange and faster innovation cycles. Companies are also launching novel microplate formats, such as ultra-low attachment plates, to support consistent and reproducible spheroid growth. Moreover, growing interest in organoids and patient-derived tumor models is increasing the demand for advanced 3D cell culture infrastructure. These developments are fostering the transition from experimental to mainstream use of spheroids in both basic research and applied biomedical sciences.

Despite strong growth, the market faces several challenges that could impact its pace of expansion. High costs of advanced spheroid platforms and consumables limit accessibility for smaller research facilities and startups. Standardization remains an issue, as protocols for spheroid formation, culture, and data interpretation often vary widely between laboratories. Regulatory uncertainties regarding the clinical translation of findings from spheroid-based models hinder wider acceptance in drug approval pipelines. Technical limitations, such as achieving uniform size and maintaining long-term viability of spheroids, also persist. In developing regions, limited awareness and lack of skilled personnel further slow adoption. Addressing these challenges through cost optimization, technical training, and cross-industry collaborations will be critical for sustaining long-term market growth.

Key Market Drivers

Rising Demand for Advanced 3D Cell Culture Models

The rising demand for advanced 3D cell culture models is significantly propelling the growth of the Global Spheroids Market. Traditional 2D culture systems often fall short in replicating human tissue complexity, frequently leading to poor predictive outcomes in drug development. Spheroids, with their three-dimensional architecture, mimic in vivo cellular environments more effectively offering benefits such as realistic oxygen gradients, enhanced cell-cell and cell-matrix interactions, and metabolite diffusion patterns. These characteristics improve translational fidelity in preclinical testing, helping to reduce costly late-stage failures in drug pipelines.

This shift toward more physiologically accurate models is backed by substantial government support. The U.S. National Institutes of Health (NIH) allocated approximately USD 27 million in 2020, increasing to about USD 28.5 million in 2021, toward its Human Biomolecular Atlas Program (HuBMAP), which focuses on single-cell resolution mapping of human tissues, underscoring growing institutional commitment to high-fidelity tissue modeling. As a broader initiative, NIH's emphasis on funding development of 3D human tissue models reinforces the momentum behind model systems like spheroids.

In oncology and toxicology, spheroids are increasingly used for high-content screening, drug resistance studies, and cytotoxicity assays. Innovations in automation, microfabrication, and imaging tools are smoothing integration of these models into laboratory workflows. Regulatory bodies and funding agencies are encouraging adoption of 3D systems in line with ethical imperatives to reduce animal testing, while also enhancing experimental accuracy. This convergence of scientific need, technological readiness, and institutional endorsement positions spheroids as a vital component of modern biomedical research infrastructure, driving sustained demand across therapeutic areas and research domains.

Key Market Challenges

Lack of Standardization in Spheroid Formation and Analysis

One of the most pressing challenges faced by the Global Spheroids Market is the lack of standardization in spheroid formation and analysis. Spheroids are three-dimensional aggregates of cells used in a range of biomedical applications, but the absence of uniform protocols leads to inconsistent results, limiting their reliability and comparability across laboratories and studies. The formation of spheroids depends heavily on variables such as cell type, culture medium composition, aggregation technique, and incubation conditions. Without standardized methods, even minor deviations in these parameters can result in significant variation in spheroid size, morphology, and cellular behavior. This inconsistency becomes a barrier for researchers trying to reproduce or validate findings across different institutions, which is crucial in preclinical drug testing and disease modeling.

Another critical issue lies in the analysis of spheroids. Imaging and quantification of spheroid characteristics such as size, viability, and structural integrity often require sophisticated tools and expertise. Yet, no universally accepted protocols or metrics exist for evaluating these parameters. This variation can impact the interpretation of drug efficacy and toxicity, thereby slowing regulatory acceptance and industrial adoption. The challenge is further compounded when spheroids are integrated with co-culture systems or used in dynamic platforms such as organ-on-a-chip devices. These complex models make data interpretation even more difficult without consistent analytical guidelines.

The lack of standardization also affects scalability for commercial and clinical applications. Biotech firms developing 3D models for high-throughput screening or personalized medicine face difficulties in ensuring batch-to-batch consistency. This undermines investor confidence and hampers broader market penetration. Without established standards, regulatory bodies may also hesitate to accept spheroid-based models in place of conventional methods. The development of consensus-driven protocols, possibly through industry-academic collaborations or regulatory frameworks, will be essential to address these challenges and unlock the full potential of spheroid-based technologies.

Key Market Trends

Shift Towards High-Throughput 3D Screening Platforms

A significant trend shaping the Global Spheroids Market is the increasing shift towards high-throughput 3D screening platforms, driven by the need for more predictive, efficient, and physiologically relevant models in drug discovery and toxicology. Traditional 2D cell culture models have long been the standard in pharmaceutical research, but they often fall short in accurately replicating human tissue complexity. This has led to a growing preference for 3D spheroid-based models, which offer better cell-to-cell and cell-to-matrix interactions, making them highly suitable for simulating in vivo conditions. As the pharmaceutical industry pushes for faster and more accurate preclinical screening, high-throughput systems that can generate and analyze hundreds or thousands of spheroids simultaneously are becoming increasingly vital.

Technological advancements in microplate design, liquid handling automation, and imaging systems have enabled the development of platforms that support automated spheroid formation, culture maintenance, and real-time data collection. These innovations are allowing researchers to test multiple drug candidates across different spheroid models with greater speed and reliability. Companies are also integrating artificial intelligence and machine learning tools to streamline data analysis, enhancing decision-making in early-stage drug development. The scalability and reproducibility offered by high-throughput 3D platforms are attracting widespread interest from pharmaceutical and biotech firms aiming to reduce time-to-market for new therapies. This trend is expected to accelerate the adoption of spheroids in screening applications and drive sustained market growth.

Key Market Players

• Thermo Fisher Scientific Inc.
• Corning Incorporated
• Merck KGaA
• Lonza Group AG
• InSphero AG
• Greiner Bio-One International GmbH
• 3D Biotek LLC
• CN Bio Innovations
• Kuraray Co., Ltd.
• Tecan Group Ltd.

Report Scope:

In this report, the Global Spheroids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spheroids Market, By Type:

• Multicellular Tumor Spheroids (MCTS)
• Neurospheres
• Mammospheres
• Hepatospheres
• Embryoid Bodies

Spheroids Market, By Method:

• Micropatterned Plates
• Low Cell Attachment Plates
• Hanging Drop Method
• Others

Spheroids Market, By Source:

• Cell Line
• Primary Cell
• iPSCs Derived Cells

Spheroids Market, By Application:

• Developmental Biology
• Personalized Medicine
• Regenerative Medicine
• Disease Pathology Studies
• Drug Toxicity & Efficacy Testing

Spheroids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spheroids Market.

Available Customizations:

Global Spheroids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Spheroids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies)
  • 5.2.2. By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others)
  • 5.2.3. By Source (Cell Line, Primary Cell, iPSCs Derived Cells)
  • 5.2.4. By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Spheroids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Method
  • 6.2.3. By Source
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spheroids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Source
      • 6.3.1.2.4. By Application
  • 6.3.2. Mexico Spheroids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Source
      • 6.3.2.2.4. By Application
  • 6.3.3. Canada Spheroids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Source
      • 6.3.3.2.4. By Application

7. Europe Spheroids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Method
  • 7.2.3. By Source
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spheroids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Source
      • 7.3.1.2.4. By Application
  • 7.3.2. Germany Spheroids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Source
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Spheroids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Source
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Spheroids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Source
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Spheroids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Source
      • 7.3.5.2.4. By Application

8. Asia-Pacific Spheroids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Method
  • 8.2.3. By Source
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Spheroids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Source
      • 8.3.1.2.4. By Application
  • 8.3.2. India Spheroids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Source
      • 8.3.2.2.4. By Application
  • 8.3.3. South Korea Spheroids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Source
      • 8.3.3.2.4. By Application
  • 8.3.4. Japan Spheroids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Source
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Spheroids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Source
      • 8.3.5.2.4. By Application

9. South America Spheroids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Method
  • 9.2.3. By Source
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spheroids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Source
      • 9.3.1.2.4. By Application
  • 9.3.2. Argentina Spheroids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Source
      • 9.3.2.2.4. By Application
  • 9.3.3. Colombia Spheroids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Source
      • 9.3.3.2.4. By Application

10. Middle East and Africa Spheroids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Method
  • 10.2.3. By Source
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spheroids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Source
      • 10.3.1.2.4. By Application
  • 10.3.2. Saudi Arabia Spheroids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Source
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Spheroids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Source
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Corning Incorporated
• 15.3. Merck KGaA
• 15.4. Lonza Group AG
• 15.5. InSphero AG
• 15.6. Greiner Bio-One International GmbH
• 15.7. 3D Biotek LLC
• 15.8. CN Bio Innovations
• 15.9. Kuraray Co., Ltd.
• 15.10. Tecan Group Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer